In view of the previous observations suggesting that IL-1β is regulated by COX-2 (Wang et al., 2012) and its potential contribution to the pathogenesis of AD (Montine et al., 1999), we first examined the response of A172 cells to a COX-2 inhibitor treatment. Here, PTGS2 is linked to Alzheimer disease.